MMP3C: an in-silico framework to depict cancer metabolic plasticity using gene expression profiles
Briefings in Bioinformatics · 2023
DOI: 10.1093/bib/bbad471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2023. Verfasst von Xingyu Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Sc…. Hauptthemen laut MEDLINE: Transcriptome, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Development Fund, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology.
Abstract (Originalsprache)
Metabolic plasticity enables cancer cells to meet divergent demands for tumorigenesis, metastasis and drug resistance. Landscape analysis of tumor metabolic plasticity spanning different cancer types, in particular, metabolic crosstalk within cell subpopulations, remains scarce. Therefore, we proposed a new in-silico framework, termed as MMP3C (Modeling Metabolic Plasticity by Pathway Pairwise Comparison), to depict tumor metabolic plasticity based on transcriptome data. Next, we performed an extensive metabo-plastic analysis of over 6000 tumors comprising 13 cancer types. The metabolic plasticity within distinct cell subpopulations, particularly interplay with tumor microenvironment, were explored at single-cell resolution. Ultimately, the metabo-plastic events were screened out for multiple clinical applications via machine learning methods. The pilot research indicated that 6 out of 13 cancer types exhibited signs of the Warburg effect, implying its high reliability and robustness. Across 13 cancer types, high metabolic organized heterogeneity was found, and four metabo-plastic subtypes were determined, which link to distinct immune and metabolism patterns impacting prognosis. Moreover, MMP3C analysis of approximately 60 000 single cells of eight breast cancer patients unveiled several metabo-plastic events correlated to tumorigenesis, metastasis and immunosuppression. Notably, the metabolic features screened out by MMP3C are potential biomarkers for diagnosis, tumor classification and prognosis. MMP3C is a practical cross-platform tool to capture tumor metabolic plasticity, and our study unveiled a core set of metabo-plastic pairs among diverse cancer types, which provides bases toward improving response and overcoming resistance in cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macao SAR 999078, China.
- CRDA, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR 999078, China.
ORCID-Profile: Chen Huang
Förderung
- Science and Technology Development Fund
- State Key Laboratory of Quality Research in Chinese Medicine
- Macau University of Science and Technology
Zitieren
APA
Chen, X., Deng, M., Wang, Z., & Huang, C. (2023). MMP3C: an in-silico framework to depict cancer metabolic plasticity using gene expression profiles. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbad471
Vancouver
Chen X, Deng M, Wang Z, Huang C. MMP3C: an in-silico framework to depict cancer metabolic plasticity using gene expression profiles. Briefings in Bioinformatics. 2023. doi:10.1093/bib/bbad471
BibTeX
@article{Chen2023,
author = {Chen, Xingyu and Deng, Min and Wang, Zihan and Huang, Chen},
title = {MMP3C: an in-silico framework to depict cancer metabolic plasticity using gene expression profiles},
journal = {Briefings in Bioinformatics},
year = {2023},
doi = {10.1093/bib/bbad471}
}
EUVIMED